- Home
- TNYA vs SGMO Comparison
TNYA vs SGMO Comparison
Compare TNYA & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNYA | SGMO |
|---|---|---|
| Founded | 2016 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.9M | 131.2M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TNYA | SGMO |
|---|---|---|
| Price | $0.80 | $0.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $5.25 | ★ $5.75 |
| AVG Volume (30 Days) | 3.9M | ★ 8.3M |
| Earning Date | 03-09-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $32,875,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $0.35 |
| 52 Week High | $2.35 | $1.40 |
Technical Indicators
Market Signals| Indicator | TNYA | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 42.01 |
| Support Level | $0.75 | $0.35 |
| Resistance Level | $0.94 | $0.60 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 39.60 | 5.29 |
Price Performance
Historical ComparisonAbout TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.